Apollo Global Management Ord Shs vs AstraZeneca plc — how do they compare? Apollo Global Management Ord Shs trades at $140.98 (market cap $82.84B), while AstraZeneca plc trades at $158.11 (market cap $248.14B). The key difference: AstraZeneca plc is far larger — about 3× Apollo Global Management Ord Shs's market cap, and AstraZeneca plc pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| APO | AZN | |
|---|---|---|
Market Cap | $82.84B | $248.14B |
Sector | Financials | Health |
52-Week High | $152.70 | $209.48 |
52-Week Low | $100.30 | $147.06 |
Enterprise Value | -$168.65B | $275.41B |
Dividend Yield | 1.6% | 2.01% |
Trailing returns across standard periods
Latest headlines on both assets
Apollo Global Management Inc is an alternative investment manager. It serves various sectors such as chemicals, manufacturing and industrial, natural resources, consumer and retail, consumer services, business services, financial services, leisure, and media and telecom and technology. The company operates in three business segments that are Private Equity, Credit, and Real Assets. It generates maximum revenue from the Credit segment in the form of fees. The credit segment primarily invests in non-control corporate and structured debt instruments including performing, stressed and distressed instruments across the capital structure. It also includes Corporate Credit
Read more on APO →A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →